Frontotemporal Dementia (FTD) - Epidemiology Forecast - 2032

Frontotemporal Dementia Disease Understanding

FTD is a term used to describe a group of neurocognitive disorders that encompass progressive dysfunction in executive functioning, behavior, and language. There are three types of frontotemporal disorders (FTD): behavioral variant frontotemporal dementia (bvFTD), primary progressive aphasia (PPA), and movement disorders.

Frontotemporal Dementia Diagnosis

Frontotemporal Dementia Epidemiology Perspective

Key Findings

• Total diagnosed prevalent cases of FTD in the 7MM was found to be 128,570 in 2021, which might increase by the end of 2032. These cases are expected to increase at a CAGR of 0.3% during study period (2019-2032).
• Among 7MM, the United States has the highest prevalent cases of FTD with 58,960 cases in 2021.
• On the basis of type-specific diagnosed prevalent cases of FTD, bvFTD accounted for highest number of cases in 2021 with 35,846 cases in the United States.
• Among the European countries, Germany had the highest diagnosed prevalent population of FTD with 14,856 cases, followed by the France with 11,983 cases in 2021. On the other hand, Spain had the lowest diagnosed prevalent population.
• Japan accounted for 11,845 diagnosed prevalent cases of FTD in the year 2021 which are expected to decrease during the forecasted period (2022-2032).

Scope of the Report

• The report covers the descriptive overview of FTD, explaining its symptoms, etiology, pathogenesis, and various diagnostic approaches.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report assesses the disease risk and burden of FTD.
• The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
• The report provides the segmentation of the disease epidemiology for 7MM diagnosed prevalent cases of frontotemporal dementia, type-specific diagnosed prevalent cases of frontotemporal dementia, and gene-specific diagnosed prevalent cases of frontotemporal dementia.

Report Highlights

• 11-Year Forecast of Frontotemporal Dementia
• The 7MM Coverage
• Total diagnosed prevalent cases of Frontotemporal Dementia
• Type-specific prevalent cases of Frontotemporal Dementia
• Gene-specific prevalent cases of Frontotemporal Dementia

Key Questions Answered

• What are the disease risk and burdens of Frontotemporal Dementia?
• What is the historical Frontotemporal Dementia patient pool in the United States, the EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
• What would be the forecasted patient pool of Frontotemporal Dementia at the 7MM level?
• What will be the growth opportunities across the 7MM concerning the patient population about Frontotemporal Dementia?
• Out of the above-mentioned countries, which country would have the highest diagnosed prevalent population of Frontotemporal Dementia during the forecast period (2022-2032)?
• At what CAGR the population is expected to grow across the 7MM during the forecast period (2022-2032)?

Reasons to Buy

• Develop business strategies by understanding the trends shaping and driving the 7MM Frontotemporal Dementia epidemiology forecast.
• The Frontotemporal Dementia epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
• The Frontotemporal Dementia epidemiology model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered

• The United States
• The EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan